id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
10_1101-2021_02_09_430405	Quazi, Sameer	<em>In-silico</em> Structural and Molecular Docking-Based Drug Discovery Against Viral Protein (VP35) of Marburg Virus: A potent Agent of MAVD	2021	23	.pdf	application/pdf	5941	1038	64	In-silico Structural and Molecular Docking-Based Drug Discovery Against Viral Protein (VP35) of Marburg Virus: A potent Agent of MAVD including structure-based drug-like compounds screening from online databases, molecular The final small molecules of drug-like compounds would have more effective and selected for the molecular docking with FGI-103 antiviral drug-using AutoDock 4.2 software. After that, FGI-103 was set and screen other drug-like compounds from PubChem databases. The finally selected drug-like compounds were docked with the P1 site of VP35 of based on ap1 site for ligand in every dock for VP35 MARV utilizing a grid chart of 50 × 50 × 50 The ADMET properties of finally selected drug-like compounds were checked to utilize 2D molecules structure of selected drug-like compounds (A) represents the 2D The molecule structure of three drug-like compounds is shown in Figure 6. "In-Silico Structural and Molecular Docking-Based Drug Discovery "In-Silico Structural and Molecular Docking-Based Drug Discovery 	./cache/10_1101-2021_02_09_430405.pdf	./txt/10_1101-2021_02_09_430405.txt